Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Cavanagh

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
BMJ Open|October 3, 2019
Impact of major depression on cardiovascular outcomes for individuals with hypertension: prospective survival analysis in UK BiobankNicholas Graham, Joey Ward, Daniel Mackay, et al.
Annals of the Rheumatic Diseases|April 8, 2010
Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept studyJonathan Cavanagh, Carolyn Paterson, John McLean, et al.
Acta Neurologica Scandinavica|February 1, 2020
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological studyCallum R Smith, Breda Cullen, Matthew P Sheridan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 5, 2016
Relationship Between Blood Pressure Values, Depressive Symptoms, and Cardiovascular Outcomes in Patients With Cardiometabolic DiseaseBhautesh Dinesh Jani, Jonathan Cavanagh, Sarah J E Barry, et al.
Maturitas|January 14, 2014
Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal womenJenifer Sassarini, Rajeev Krishnadas, Jonathan Cavanagh, et al.
Journal of Family Medicine and Primary Care|August 20, 2015
The effects of anti-depressants on depression symptom scores at 12 months follow-up in patients with cardiometabolic disease: Results from a large primary care cohortBhautesh Dinesh Jani, David Purves, Sarah J E Barry, et al.
BMC Cardiovascular Disorders|October 30, 2014
Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional studyBhautesh Dinesh Jani, Jonathan Cavanagh, Sarah J E Barry, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-upBhautesh Dinesh Jani, Charles Boachie, Colin McCowan, et al.
Journal of Visualized Experiments : Jove|July 17, 2023
Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate ImmunityAlistair Gamble, Maria Suessmilch, Anniek Bonestroo, et al.
RMD Open|October 31, 2020
Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease featuresGeorge E Fragoulis, Jonathan Cavanagh, Alistair Tindell, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
BMJ Open|October 3, 2019
Impact of major depression on cardiovascular outcomes for individuals with hypertension: prospective survival analysis in UK BiobankNicholas Graham, Joey Ward, Daniel Mackay, et al.
Annals of the Rheumatic Diseases|April 8, 2010
Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept studyJonathan Cavanagh, Carolyn Paterson, John McLean, et al.
Acta Neurologica Scandinavica|February 1, 2020
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological studyCallum R Smith, Breda Cullen, Matthew P Sheridan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 5, 2016
Relationship Between Blood Pressure Values, Depressive Symptoms, and Cardiovascular Outcomes in Patients With Cardiometabolic DiseaseBhautesh Dinesh Jani, Jonathan Cavanagh, Sarah J E Barry, et al.
Maturitas|January 14, 2014
Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal womenJenifer Sassarini, Rajeev Krishnadas, Jonathan Cavanagh, et al.
Journal of Family Medicine and Primary Care|August 20, 2015
The effects of anti-depressants on depression symptom scores at 12 months follow-up in patients with cardiometabolic disease: Results from a large primary care cohortBhautesh Dinesh Jani, David Purves, Sarah J E Barry, et al.
BMC Cardiovascular Disorders|October 30, 2014
Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional studyBhautesh Dinesh Jani, Jonathan Cavanagh, Sarah J E Barry, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-upBhautesh Dinesh Jani, Charles Boachie, Colin McCowan, et al.
Journal of Visualized Experiments : Jove|July 17, 2023
Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate ImmunityAlistair Gamble, Maria Suessmilch, Anniek Bonestroo, et al.
RMD Open|October 31, 2020
Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease featuresGeorge E Fragoulis, Jonathan Cavanagh, Alistair Tindell, et al.
Pageof 12